Liver and Biliary Pathology Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Liver and Biliary Pathology. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Liver and Biliary Pathology Indian Medical PG Question 1: Assertion: Beta blockers improve survival in cirrhosis with varices. Reason: They reduce cardiac output and splanchnic blood flow.
- A. Both A & R true, R doesn't explain A
- B. Both A & R true, R explains A (Correct Answer)
- C. A true R false
- D. A false R true
Liver and Biliary Pathology Explanation: ***Both A & R true, R explains A***
- **Beta blockers** improve survival in patients with **cirrhosis and varices** by reducing the risk of **variceal bleeding**, a major cause of mortality [1].
- This is achieved by lowering **portal pressure** primarily through reducing **cardiac output** (beta-1 blockade) and causing **splanchnic vasoconstriction** (beta-2 blockade), thereby decreasing splanchnic blood flow.
*Both A & R true, R doesn't explain A*
- The reasoning provided (reduction in cardiac output and splanchnic blood flow) directly explains the mechanism by which **beta blockers** reduce **portal pressure** and subsequently prevent **variceal bleeding**, thus improving survival [1].
- Therefore, the reason *does* explain the assertion.
*A true R false*
- The assertion that **beta blockers** improve survival in cirrhosis with varices is **true**.
- The reason—that they reduce cardiac output and splanchnic blood flow—is also **true** and describes their key mechanism of action in this context.
*A false R true*
- The assertion is **true**: non-selective **beta blockers** are a cornerstone in the primary and secondary prophylaxis of **variceal hemorrhage** in **cirrhosis**, improving survival.
- The reason is also **true**, as these mechanisms are well-established pharmacological effects of **beta blockers** leading to reduced **portal hypertension** [1].
Liver and Biliary Pathology Indian Medical PG Question 2: The single most important treatment and prognostic factor in alcohol-related liver disease is
- A. N -acetyl cysteine
- B. High dose vitamin E
- C. Cessation of alcohol consumption (Correct Answer)
- D. Liver transplantation
Liver and Biliary Pathology Explanation: ***Cessation of alcohol consumption***
- **Abstinence from alcohol** is the fundamental and most effective intervention for halting the progression of **alcohol-related liver disease (ARLD)** and significantly improving patient prognosis [1].
- Continued alcohol intake directly fuels liver damage, whereas stopping consumption allows the **liver to regenerate** and reduces inflammation, often leading to clinical improvement [1].
*N-acetyl cysteine*
- While **N-acetyl cysteine (NAC)** is used in some liver conditions, particularly paracetamol overdose, its routine use for chronic ARLD is not supported by strong evidence as a primary treatment [3].
- It functions as an antioxidant and glutathione precursor, but **does not address the root cause** of alcohol-induced liver injury.
*High dose vitamin E*
- **High-dose vitamin E** is an antioxidant that has been investigated for various liver diseases, particularly non-alcoholic fatty liver disease (NAFLD) [2].
- However, there is **insufficient evidence** to support its widespread use as a primary or prognostic treatment in **alcohol-related liver disease** [2].
*Liver transplantation*
- While **liver transplantation** can be a definitive treatment for end-stage ARLD, it is a **major surgical procedure** with strict criteria and is only considered after prolonged alcohol abstinence (typically 6 months) [1].
- It is a **salvage therapy** for irreversible damage, not the "single most important treatment and prognostic factor" in managing the disease from its earlier stages [1].
Liver and Biliary Pathology Indian Medical PG Question 3: Post-mortem histologic sections taken from the liver of a 19-year-old female who died from an overdose of acetaminophen would most likely reveal which of the following?
- A. Centrilobular necrosis (Correct Answer)
- B. Focal scattered necrosis
- C. Midzonal necrosis
- D. Periportal necrosis
Liver and Biliary Pathology Explanation: ***Centrilobular necrosis***
- In acetaminophen overdose, **centrilobular (zone 3) necrosis** is the most common histological finding due to the toxic effects on the liver's **zone 3 hepatocytes** [1].
- This type of necrosis correlates with **reduced blood flow** and increased toxicity in the central regions of liver lobules [1].
*Periportal necrosis*
- Typically associated with **ischemic injury** or **viral hepatitis**, not acetaminophen toxicity.
- Involves the peripheral areas of the liver lobules and does not reflect the pattern seen in overdose cases.
*Midzonal necrosis*
- This type of necrosis involves the middle zones (zone 2) of the liver, which are not predominantly affected in acetaminophen toxicity.
- Usually seen in conditions like **carbon tetrachloride poisoning** or **cholestasis**, rather than acetaminophen-induced liver damage.
*Focal scattered necrosis*
- This description implies random areas of necrosis, which is not characteristic of acetaminophen toxicity.
- Necrosis is usually more prominent and centralized, especially around the **centrilobular region** in cases of overdose [1].
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 832.
Liver and Biliary Pathology Indian Medical PG Question 4: A 30-year-old male is found to be positive for HBsAg and HBeAg and is diagnosed with chronic hepatitis B. The patient's viral load is 2 × 10^5 IU/mL and ALT is elevated (2× upper limit of normal). What is the appropriate management in this patient?
- A. Combined pegylated interferon with lamivudine
- B. Pegylated interferon
- C. Lamivudine
- D. Tenofovir (Correct Answer)
Liver and Biliary Pathology Explanation: Tenofovir
- This patient presents with chronic hepatitis B (HBsAg positive for >6 months), evidence of active viral replication (HBeAg positive, high viral load), and liver inflammation (elevated ALT). [3] This signifies chronic active hepatitis B, requiring treatment. [1]
- Tenofovir is a highly potent nucleotide analog with a high barrier to resistance, making it a first-line treatment for chronic hepatitis B.
*Lamivudine*
- While an antiviral for HBV, lamivudine has a low genetic barrier to resistance, meaning resistance mutations can rapidly develop, reducing its long-term efficacy.
- Due to the high risk of resistance, lamivudine is generally not recommended as a first-line monotherapy for treatment-naive patients with chronic hepatitis B, especially with a high viral load.
*Pegylated interferon*
- Pegylated interferon is an option for chronic hepatitis B, but it causes significant side effects (e.g., fatigue, depression, bone marrow suppression) and is usually administered by injection. [2]
- Its efficacy in achieving sustained HBeAg seroconversion or HBsAg loss can be variable, and it is often reserved for patients who prefer a finite course of treatment and can tolerate the side effects, or for those without advanced liver disease. [2]
*Combined pegylated interferon with lamivudine*
- There is no significant evidence that combining pegylated interferon with lamivudine offers superior efficacy compared to monotherapy with a potent nucleos(t)ide analog like tenofovir or entecavir.
- This combination would increase the side effect burden from interferon and still carry the risk of lamivudine resistance without substantial added benefit.
Liver and Biliary Pathology Indian Medical PG Question 5: Which of the following is NOT a pathological manifestation of chronic alcoholism?
- A. Piecemeal necrosis (Correct Answer)
- B. Microvesicular fatty changes
- C. Central hyaline sclerosis
- D. Ballooning degeneration
Liver and Biliary Pathology Explanation: ***Piecemeal necrosis***
- Piecemeal necrosis is not a common manifestation of chronic alcoholism but is instead more typical of **autoimmune hepatitis** or **chronic viral hepatitis**.
- Chronic alcoholism primarily leads to different types of liver damage, such as **steatosis** or **apoptosis**, rather than piecemeal necrosis.
*Balloning degeneration*
- Balloning degeneration reflects **swelling** of hepatocytes, often associated with **alcoholic liver disease** and represents liver cell injury [1].
- It is a recognized feature seen in chronic alcohol exposure indicating the effect of toxicity on liver cells [1].
*Microvesicular fatty changes*
- Microvesicular fatty changes, characterized by small fat vacuoles in liver cells, can be induced by chronic alcohol use and is commonly noted in **steatosis** [2].
- This finding is also seen in conditions like **reye syndrome** and is closely related to alcohol-induced liver injury.
*Central hyaline sclerosis*
- Central hyaline sclerosis refers to fibrosis and is often related to chronic liver disease but is not a direct pathological manifestation seen in chronic alcoholism.
- However, chronic alcohol abuse contributes to **cirrhosis**, which can lead to various forms of liver scarring, but this is not specific to alcohol alone [3].
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 848-850.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 848.
More Liver and Biliary Pathology Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
